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Early Alzheimer’s disease can involve social disinvestment, possibly as a consequence of
impairment of nonverbal communication skills. This study explores whether patients with
Alzheimer’s disease at the mild cognitive impairment or mild dementia stage have impaired
recognition of emotions in facial expressions, and describes neuroanatomical correlates of
emotion processing impairment. As part of the ongoing PACO study (personality, Alzhei-
mer’s disease and behaviour), 39 patients with Alzheimer’s disease at the mild cognitive
impairment or mild dementia stage and 39 matched controls completed tests involving dis-
crimination of four basic emotions—happiness, fear, anger, and disgust—on photographs
of faces. In patients, automatic volumetry of 83 brain regions was performed on structural
magnetic resonance images using MAPER (multi-atlas propagation with enhanced registra-
tion). From the literature, we identified for each of the four basic emotions one brain region
thought to be primarily associated with the function of recognizing that emotion. We hypoth-
esized that the volume of each of these regions would be correlated with subjects’ perfor-
mance in recognizing the associated emotion. Patients showed deficits of basic emotion
recognition, and these impairments were correlated with the volumes of the expected
regions of interest. Unexpectedly, most of these correlations were negative: better emo-
tional facial recognition was associated with lower brain volume. In particular, recognition of
fear was negatively correlated with the volume of amygdala, disgust with pallidum, and hap-
piness with fusiform gyrus. Recognition impairment in mild stages of Alzheimer’s disease
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for a given emotion was thus associated with less visible atrophy of functionally responsible
brain structures within the patient group. Possible explanations for this counterintuitive
result include neuroinflammation, regional β-amyloid deposition, or transient overcompen-
sation during early stages of Alzheimer’s disease.
Introduction
Interpersonal communication relies on verbal conversation, but also on non-verbal cues such
as facial emotional expressions. Interpreting facial expressions is crucial to recognition of the
mental state of others and to successful social interaction. In Alzheimer’s disease (AD), these
skills are impaired [1–3], and this impairment can lead to compromised communication and
increased caregiver burden. AD is characterized at the early stages by an episodic memory
decline, but other cognitive domains, like executive function and social cognition, may also be
impaired [3, 4].
Previous work yielded inconsistent results concerning AD patients’ abilities to recognize
emotions on faces. Most of the relevant studies report specific impairments for sadness, anger
and fear [2, 5, 6]. However, only a few studies [3, 7–10] investigated this ability at early stages
corresponding to mild cognitive impairment (MCI) or prodromal and mild dementia stages of
AD. MCI is a transitional state between normal ageing and dementia, where patients present
some deficits of cognition with relatively preserved activities of daily living and autonomy [11].
AD at the MCI or mild dementia stage is characterized by episodic memory impairment, cog-
nitive decline to various degrees, and entorhinal cortex and hippocampal atrophy [12], as well
as amygdala atrophy [13, 14]. As early atrophy occurs in brain regions crucial for emotion pro-
cessing, it might be linked to social disinvestment and behavioural symptoms, early social cog-
nition impairment, and emotion recognition impairment.
Emotions can be classified into three categories: basic emotions (happiness, surprise, sad-
ness, fear, anger, and disgust), motivational states, and social emotions [15]. Facial emotional
expressions usually reflect someone's emotional state and are part of social communication.
Fast early perceptual processing of emotional facial expressions involves the thalamus, amyg-
dala, superior colliculus, and striate cortex [16]. Detailed perception and conceptualization of
the emotion signaled by the face engages the striate cortex, fusiform face area, superior tempo-
ral gyrus (STG), amygdala, orbitofrontal cortex (OFC), basal ganglia, hypothalamus, insula
and brainstem [17,18]. As part of multiple specialized networks, the amygdala is particularly
important for the recognition of fear [19], the anterior insula for disgust [20–22], the ventral
striatum and the OFC for anger [23], and the amygdala along with the supplementary motor
area for the recognition of happiness [24, 25].
The aim of this study was to better specify the early emotion recognition deficits at mild
stages of AD and to disentangle their neuroanatomical correlates. We performed facial emo-
tional expression recognition testing in patients diagnosed with AD at the MCI or mild demen-
tia stage, as well as in healthy controls. Only the patient group had 3D structural magnetic
resonance (MR) brain imaging. The patients and controls underwent tests to assess their ability
to recognize facial expressions of anger, fear, disgust and happiness. Volumes of individual
brain regions were obtained by processing the 3D T1-weighted images with MAPER (multi-
atlas propagation with enhanced registration) [14, 26]. Correlations between cognitive perfor-
mance and regional volumes were assessed.
Correlates of Recognizing Emotion in Early Alzheimer’s Disease
PLOS ONE | DOI:10.1371/journal.pone.0143586 December 16, 2015 2 / 17
Health Grant U01 AG024904) and DOD ADNI
(Department of Defense award number W81XWH-
12-2-0012). ADNI is funded by the National Institute
on Aging, the National Institute of Biomedical Imaging
and Bioengineering, and through generous
contributions from the following: AbbVie, Alzheimer’s
Association; Alzheimer’s Drug Discovery Foundation;
Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-
Myers Squibb Company; CereSpir, Inc.; Eisai Inc.;
Elan Pharmaceuticals, Inc.; Eli Lilly and Company;
EuroImmun; F. Hoffmann-La Roche Ltd and its
affiliated company Genentech, Inc.; Fujirebio; GE
Healthcare; IXICO Ltd.; Janssen Alzheimer
Immunotherapy Research & Development, LLC.;
Johnson & Johnson Pharmaceutical Research &
Development LLC.; Lumosity; Lundbeck; Merck &
Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx
Research; Neurotrack Technologies; Novartis
Pharmaceuticals Corporation; Pfizer Inc.; Piramal
Imaging; Servier; Takeda Pharmaceutical Company;
and Transition Therapeutics. The Canadian Institutes
of Health Research is providing funds to support
ADNI clinical sites in Canada. Private sector
contributions are facilitated by the Foundation for the
National Institutes of Health (www.fnih.org). The
grantee organization is the Northern California
Institute for Research and Education, and the study is
coordinated by the Alzheimer’s Disease Cooperative
Study at the University of California, San Diego. ADNI
data are disseminated by the Laboratory for Neuro
Imaging at the University of Southern California. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: Prof. Hammers is the inventor
of the atlases used in this paper. Maximum probability
maps based on these atlases have been licensed to
industry via Imperial Innovations plc. The other
authors have declared that no competing interests
exist. This does not alter the authors’ adherence to
PLOS ONE policies on sharing data and materials.
Material and Methods
This study is part of the PACO (personnalité Alzheimer comportement—personality, Alzhei-
mer’s disease, and behaviour) programme (Clinical Trial number 01297140), a national collab-
orative programme evaluating patients diagnosed with AD at the MCI or mild dementia
stages. PACO prospectively explores the role of personality and social clue recognition abilities
in the occurrence of behavioural disorders later in the disease course.
Participants
Thirty-nine patients diagnosed with AD at the amnestic MCI stage [11] (n = 15) or the mild
dementia stage [27] (n = 24) and 39 healthy control subjects took part in this study. All partici-
pants were diagnosed by a board-qualified neurologist with extensive experience in neurode-
generative diseases. Patients were diagnosed either with mild stage dementia according to the
Clinical Dementia Rating (CDR) 1 & 2 [28], or with prodromal AD. Patients with prodromal
AD, corresponding to amnestic mild cognitive impairment (aMCI) [29] had a clinical demen-
tia rating criteria of 0.5 as set out in the PréAL study and the revised NINCDS-ADRDA diag-
nostic criteria suggested for research purposes [30]. Patients scored 20/30 or higher on the
Mini Mental State Examination (MMSE [31]); control subjects scored 28/30 or higher.
Further inclusion criteria were age (> 50 years), sufficient visual, auditory and French lan-
guage skills to complete the clinical evaluations, and the availability of a caregiver able to report
on patient personality and behaviour. Patients had no progressive or poorly managed psychiat-
ric pathology, were not taking any antipsychotic or psychotropic medication unless chronically
and at stable doses, had no evidence for non-AD related disease and were not depressed. All
patients enrolled in the PACO program so far who had MR data available were included in the
present study.
Inclusion required written consent from both the patient and a caregiver who was closely
involved with the patient. In compliance with French law, the study protocol, inclusion criteria,
and consent procedure were reviewed and approved by the responsible regional ethics commit-
tee (Comité de Protection des Personnes South-East III) and the Agence Nationale de Sécurité
du Médicament et des Produits de Santé. Participation was not remunerated.
Participants’ demographical data are presented in Table 1.
Behavioural tasks
For the two cognitive tasks described below, photographs of faces and answer options were dis-
played on a computer screen. The tasks were not timed, but participants were asked to answer
Table 1. Demographical and neuropsychological characteristics of the studied sample.
Controls Patients Controls vs patients
Number 39 39 ns
Male / Female 13 / 26 19 / 20 ns
Age [min–max] 70.2 (7.2) [59–87] 79.9 (4.7) [70–88] p<10−7
Education level [min–max] 3.5 (0.7) [1–4] 2.6 (0.9) [1–4] p<10−5
MMS (score/30) [min–max] 29.3 (0.7) [28–30] 23.9 (2.5) [20–29] p<10−12
Values are presented as mean (SD). The two groups were compared using Student’s t-test (education level) or the Wilcoxon test (age and MMS).
Education level: 1: no study degree, 2: “certiﬁcat d’études” (5 years of formal education), 3: “brevet” (9 years of formal education), 4: baccalaureate (12
years of formal education) or higher. MMS: Mini-mental state examination. Patients: AD at the MCI stage or at the mild dementia stage.
Min: minimum, max: maximum.
doi:10.1371/journal.pone.0143586.t001
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as spontaneously as possible. Participants gave their answer verbally and the examiner selected
the chosen label on the computer screen. No feedback on responses was provided. Two of the
patients did not participate in the gender recognition task. All of the stimuli were developed,
validated and used in a previous study by Bediou et al. (2005) [32].
Facial gender recognition task
This task measures the ability to discriminate the gender from face images in order to rule out
deficits of attention, vision, or face structural encoding. As a control task, it ensured that any
deficits observed in the facial emotional expression recognition task were specifically due to an
impaired ability to recognize emotions.
Photographic images of males and females were morphed with a gender-neutral face to cre-
ate a gender continuum. The neutral face was obtained by averaging 20 male and 20 female
faces. For each male and each female face, a range of six intensity levels of sex features (0%,
20%, 40%, 60%, 80% and 100%) was obtained by computer graphical manipulation [3].
Ninety-six items using 16 different models (eight women) were randomly presented, and par-
ticipants were asked to determine whether the face was more feminine or masculine.
Facial emotional expression recognition task
This task evaluates the recognition of four basic emotions: happiness, anger, disgust, and fear
[3]. Photographs of facial expressions were morphed with photographs of neutral expressions
to create images representing varying degrees (20, 40, 60, 80, or 100%) of the emotional expres-
sion. Twenty items for each emotion and 16 neutral faces were presented in random order. Par-
ticipants were asked to select the label that best described the emotional expression, i.e.
“anger”, “fear”, “disgust”, “happiness”, or “neutral”.
We used various morphing degrees as we hypothesized that early-stage disease might only
affect recognition of the subtlest facial emotional expressions (20% of intensity for instance),
while recognition of more distinct expressions might still be intact.
The unprocessed results spreadsheet of the behavioural tests is provided as a supplement
(S1 File).
Structural MR image processing
MR image acquisition. Cranial MR scanning was performed at the time of diagnosis or
no later than three months after the cognitive tasks, and only on patients. All sequences (3D
T1, axial T2, T2 and FLAIR) were acquired at 1.5 Tesla Philips Achieva scanners at university
hospitals in Lyon and Saint-Etienne. A research engineer set up the exact same MR imaging
protocol on both sites to ensure that acquisition parameters were identical at both participating
hospitals. For volumetric analyses, 1 mm isotropic 3D T1 sequences without contrast injection
were performed.
Since our control group did not undergo MR scanning, we used healthy subjects who partic-
ipated in the Alzheimer’s Disease Neuroimaging Initative (ADNI) as a control group to com-
pare the brain volumes of our patient group. The 3D structural MR images from the ADNI
database were segmented using the same procedures as for the patient group. We selected a
group of controls with the same age distribution and gender proportions. We only selected
controls who scored 28 or more at the MMSE, and whose MR images were acquired on a 1.5
Tesla scanner. From 254 ADNI subjects matching these criteria, we randomly selected 70 for
our control group. Two of the controls were removed on an additional exclusion criterion of
having one or more brain regions whose volumes were smaller than the mean of the control
group by more than three standard deviations.
Correlates of Recognizing Emotion in Early Alzheimer’s Disease
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Data used in the preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in
2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD.
The primary goal of ADNI has been to test whether serial MR imaging, positron emission
tomography (PET), other biological markers, and clinical and neuropsychological assessment
can be combined to measure the progression of MCI and early AD.
Image preprocessing. T1-weighted MR images were preprocessed with FSL FAST to cor-
rect for intensity variations due to field inhomogeneity, and to obtain masks of the brain and
the intracranial space. We first applied pincram, a multi-atlas procedure for brain masking
[33], with parameters chosen so as to rapidly obtain a coarse, generous brain label. This label
was applied to the original image, resulting in a masked version which was subjected to bias
correction with FSL FAST.
Corrected images were processed with pincram to label the intracranial space. Pincram
requires atlas data (T1-weighted images with reference labels). A suitable atlas for intracranial
masking was obtained by selecting subjects from the IXI cohort (n = 29, http://brain-
development.org/) with intracranial masks obtained through reverse brain masking [34]. In a
subset of the resulting pincram extractions of the PACO images (n = 18), we observed segmen-
tation errors (partial exclusion of gyral crowns and partial inclusion of meninges). We there-
fore generated new atlases for pincram using PACO images where the extraction was rated
successful on visual review (n = 21). These secondary PACO-customized atlases were then
applied to all PACO images. No underinclusion problems were subsequently detected on visual
review. The resulting brain masks included most of the peripheral cerebrospinal fluid (CSF),
even in subjects with substantial brain atrophy. They were thus suitable for estimating the
intracranial volume. However, the region anterior to the brainstem was frequently included in
the mask, leading to mesiotemporal overestimations. Tighter masks labeling the brain rather
than the intracranial space were thus additionally required.
To obtain accurate regional brain labels for the 39 PACO subjects, the images were pin-
cram-extracted using the Hammers atlases [26, 35]. These atlases were generated by manual
labeling of 83 brain regions in 30 T1-weighted cranial images of adults. With this extraction,
most of the peripheral CSF was excluded from the label and the mask followed the gyral surface
with high accuracy. However, for eight subjects, the procedure resulted in substantial over- or
underinclusions. In seven of these cases, we reverted to the masks obtained with the PACO-cus-
tomized atlases. In one subject, a suitable image could not be recovered because of substantial
differences in the acquisition parameters. This subject was finally excluded.
MAPER processing to segment brains into regions of interest. MAPER [36] was used to
segment the PACO brain images into multiple regions (Fig 1). MAPER has been shown to
yield robust results, even for subjects with ventriculomegaly, which occurs frequently in MCI
and mild AD, and yields accurate segmentations for images obtained in multicenter settings
[14]. MAPER uses input in the form of multi-subject, multi-region input atlases. Here, we used
the Hammers atlases (thirty subjects, manually segmented into 83 regions according to strict
protocols) [26, 35]. Tissue classification information is incorporated into the image registration
process. A grey matter mask based on FSL FAST tissue classification was applied to the 83
regions, except for pure grey matter regions, i.e. the basal ganglia and the amygdala. Regional
volumes obtained were normalize through division by the intracranial volume. Selected regions
of interest were additionally analyzed volumetrically without this normalization.
Every segmented brain image was visually checked, especially in the regions of interest. In
addition, the regions with the smallest and largest volumes were visually checked on the corre-
sponding image to ensure that their segmentation was accurate.
Correlates of Recognizing Emotion in Early Alzheimer’s Disease
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Preprocessed MR images as subjected to analysis, along with segmentation results, are pub-
licly available [37].
Statistical analysis
The variables of interest showed no difference in variance (tested using Fisher variance test)
and were normally distributed (tested using the Shapiro test). Thus, they were suitable for
parametric analyses.
Demographical and cognition variables were analyzed using two-tailed Student's t-tests or
Wilcoxon tests when comparing the patient group (MCI and mild AD) with the control group.
The groups were well matched for sex, but differed significantly in age (patients were older,
p<10–5) and education level (patients had lower education level, p<10–5). To take this differ-
ence into account, analysis of covariance (ANCOVA) was applied with age, sex, and education
level as a covariate. Correlations between performance on the emotion recognition task and
volumes of brain regions were examined using Pearson analysis. We studied correlations based
on our regions of interest, and corrected for multiple comparisons using Benjamini & Hoch-
berg’s method [38]. Nine bilateral regions were investigated for anger recognition (putamen,
posterior STG, fusiform gyrus, anterior cingulate gyrus (ACG), precentral gyrus, anterior
orbital gyrus, inferior frontal gyrus (IFG), gyrus parahippocampalis, lingual gyrus), seven bilat-
eral regions for disgust (insula, caudate nucleus, putamen, pallidum, IFG, posterior STG,
ACG), ten bilateral regions for fear recognition (amygdala, hippocampus, posterior STG, fusi-
form gyrus, ACG, thalamus, anterior orbital gyrus, IFG, medial orbital gyrus, lateral orbital
gyrus) and seven bilateral regions for happiness recognition (amygdala, fusiform gyrus, insula,
ACG, anterior orbital gyrus, lingual gyrus, medial orbital gyrus). All statistical analyses were
performed using R (http://www.r-project.org). The threshold for statistical significance was set
at p<0.05.
Previously, Perrin et al. [39] had manually segmented the amygdala of ten of our patients
using a different protocol to that used for the Hammers atlases. Their measurements of
Fig 1. Pincram brain extraction andMAPER segmentation.MRI T1 sequences were processed with pincram, followed by MAPER and grey matter
masking to obtain regional grey matter volumes. Extraction P was used to estimate the intracranial volume. Pincram extractionH: Brain extraction using the
Hammers atlases; Pincram extraction P: Brain extraction using the PACO-customized atlases.
doi:10.1371/journal.pone.0143586.g001
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amygdala volumes were systematically larger but strongly consistent with the MAPER mea-
surements (right amygdala: ICC 0.84; left: ICC = 0.86).
Results
Behavioural tasks
Gender recognition performance. As expected, no significant difference was found
between the patient and the control groups for any of the conditions on the gender recognition
task (patients: 74% in average, controls: 79% in average) (Fig 2A).
Emotion recognition performance. On average, patients performed below controls on
emotion recognition (57% vs 69%, p<10−10). The two groups showed similar performance on
the recognition of neutral expressions (p>0.05). When averaging the five degrees of morphing
for each emotion, we found the patient group to be significantly impaired in the recognition of
anger (mean performance: 48% vs. 64%, p<10−4), fear (mean performance: 45% vs. 58%,
p<10−4), disgust (mean performance: 60% vs 68%, p = 0.049), and happiness (mean perfor-
mance: 75% vs 84%, p<10−4) (Fig 2B).
Detailed analysis of individual emotions by degree of morphing intensity. Analysis of
individual emotions revealed a variable pattern (Fig 2C to 2F). In comparison to the control
group, the patient group was impaired in anger recognition with morphing intensities of 40–
100% (from p<0.02 to p<10−4), fear recognition with morphing intensities of 40–100% (from
p<10−2 to 10−4), disgust recognition with morphing intensity of 40% (p<10−2), and happiness
recognition with morphing intensities of 20–60% (from p<10−2 to p<10−4) and 100%
(p<10−2).
Covariance with demographical data. Analysis including all participants revealed that
global emotion recognition performance deteriorated with age (r = −0.42). Age was negatively
correlated with recognition of anger (r = −0.38), fear (r = −0.30), and happiness (r = −0.30).
Structural imaging findings. Regional segmentation succeeded on every region, except
for the cerebellum, which appeared to be slightly underestimated in some subjects. Using
MAPER, we segmented 76 regional volumes corresponding to the 83 regions without the cere-
bellum and ventricles, and considered our regions of interest defined prior to the segmentation.
Shapiro tests indicated that the volumes of the regions of interest were normally distributed.
Neuroanatomical correlates
Correlations with emotion recognition performance. In the following analysis, the
impaired recognition (IR) condition corresponds to the patients’ average emotion recognition
performance at morphing degrees where they performed significantly below controls. For
instance, anger IR corresponds to the patients’ average performance on anger recognition with
morphing degrees of 40, 60, 80, and 100%.
We investigated correlations between brain regional volume and performance and corrected
for multiple comparisons as described in the Methods section (Table 2). Fear performance was
negatively correlated with the right and left amygdala volumes for varying degrees of morphing
(Fig 3C and 3D). Disgust (with 20% of morphing) was negatively correlated with the volume of
the left pallidum (Fig 3A). Happiness recognition was negatively correlated with the volume of
the left fusiform gyrus (Fig 3B). No significant correlations were revealed with anger recogni-
tion when correcting for multiple comparisons. However, without this level of correction, neg-
ative correlations between anger recognition and the right lingual gyrus volume were seen
(average of morphing degrees and IR: both r = −0.42, p = 0.008).
An overall analysis of the 76 regions without correction for multiple comparisons revealed
that most of the volumes of brain regions were negatively correlated with performance on the
Correlates of Recognizing Emotion in Early Alzheimer’s Disease
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Fig 2. Mean performance on cognitive tasks. A: Gender recognition; B: Emotion recognition; C: Anger recognition; D: Fear recognition; E: Disgust
recognition; F: Happiness recognition. Examples of morphed faces depicting various intensities of the emotional expression are shown at the bottom of each
graph. Blue: patients (AD at the MCI stage or at the mild dementia stage); Green: controls. *p <.05; **p<10–2; ***p<10–3; ****p<10–4.
doi:10.1371/journal.pone.0143586.g002
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emotion recognition tasks (cf. Supporting Information). The negative correlations between
fear recognition (100% of morphing) and amygdala volumes remained significant after Benja-
mini-Hochberg correction for 76 comparisons.
The correlations between fear IR performance and the amygdala volumes were compared to
those derived from the manually determined amygdala volumes [38] after normalization of the
latter by intracranial volume (n = 10). These manually determined volumes were also
Table 2. Correlations between emotion recognition performance and regional volumes in the patient group.
Brain region Facial expression Condition Side r p-value
uncorrected corrected
Amygdala Fear 100% of morphing L -0.40 p<10−3 p = 0.009
R -0.47 p<10−3 p = 0.007
Average R -0.36 p = 0.002 p = 0.047
IR R -0.36 p = 0.002 p = 0.046
Fusiform G. Happiness Average L -0.47 p = 0.003 p = 0.037
IR L -0.51 p = 0.001 p = 0.015
Pallidum Disgust 20% of morphing L -0.49 p = 0.002 p = 0.022
doi:10.1371/journal.pone.0143586.t002
Fig 3. Neuroanatomical correlates of emotion recognition in patients with AD at the MCI stage or at the mild dementia stage. The graphics show the
significant correlations between regional volumes normalized by the intracranial volume and performance for disgust recognition (A), happiness recognition
(B), and fear recognition (C-D). IR: impaired recognition condition. Measurements were obtained using Pearson’s correlation tests.
doi:10.1371/journal.pone.0143586.g003
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negatively correlated with the recognition of fear 100% (right: r = −0.72, p = 0.018; left: r =
−0.78, p<10−2).
To exclude the possibility that the correlations were an artifact of normalization by intracra-
nial volume, we repeated the analysis with non-normalized volumes and obtained very similar
results (data not shown).
Comparison between MCI and AD. We repeated the correlation analysis of the previous
subsection after having grouped the patients by diagnosis (Table 3). Even when analyzed sepa-
rately, the two groups showed the correlation (albeit with lower significance, as was to be
expected due to the sample size reduction).
Correlations between regions of interest. These exploratory correlations were performed
considering the uncorrected comparison results (Supporting Information). The regional vol-
umes which were positively correlated with the recognition of an emotion were also positively
correlated among themselves (average r = 0.28, p<10−6). Similarly, the regional volumes that
were negatively correlated with the recognition of an emotion were positively correlated
among themselves (average r = 0.28, p<10−6). Regional volumes positively correlated with the
recognition of an emotion were only weakly correlated with the regions negatively correlated
with the recognition of the same emotion (average: r = 0.12, p<10−6).
(Fig 4A to 4D) shows the correlation coefficients between emotion recognition perfor-
mance, regional volumes positively correlated with the recognition of emotions, and regional
volumes negatively correlated with the recognition of emotions. When plotting the 76 regions
of interest in random order, no clear pattern of correlation is evident (Fig 4E).
Region volume comparison with healthy controls. To exclude the possibility that our
patient group was unusual with regard to the region volumes we determined, we compared
measurements on selected regions (right and left amygdala, left fusiform, left pallidum, and
hippocampus left and right mean) with those obtained on the control group selected from the
ADNI database. The volumes were significantly smaller in patients than in controls, except for
the fusiform and the pallidum. The fusiform was smaller, but not significantly so. The pallidum
was larger by 13%; however pallidum measurements tend to be inaccurate with MAPER [14].
All other structures were approximately 25% smaller. These findings are consistent with mod-
erate atrophy as expected in a patient group.
Discussion
This study revealed specific impairments in facial emotion expression recognition in patients
with AD at the MCI or mild dementia stages, whereas recognition of other facial features like
gender remains unimpaired. This is consistent with a selective impairment of recognition of
Table 3. Correlations between emotion recognition performance and regional volumes, separated by diagnosis (AD/MCI).
Brain region Facial expression Condition Side Patients with MCI Patients with mild
AD
r p r p
Amygdala Fear 100% of morphing L -0.73 0.002 -0.09 0.68
R -0.79 0.0005 -0.22 0.29
Average R -0.42 0.12 -0.32 0.12
IR R -0.46 0.087 -0.31 0.13
Fusiform G. Happiness Average L -0.66 0.007 -0.29 0.17
IR L -0.72 0.002 -0.32 0.13
Pallidum Disgust 20% of morphing L -0.55 0.034 -0.50 0.01
doi:10.1371/journal.pone.0143586.t003
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Fig 4. Correlations between neuroanatomical structure volumes and emotion recognition performance. The plots show the correlation coefficients (r)
between the different conditions. Only the regions which were significantly correlated (uncorrected p-values) with the recognition of an emotion are
presented. E = Emotion recognition performance; R+ = Regional volume positively correlated with the recognition of emotions; R- = Regional volume
negatively correlated with the recognition of emotions; e.g. E/R+ = correlation between emotion recognition performance and regional volumes positively
correlated with the recognition of emotions. R = right, L = left, IR: impaired recognition.
doi:10.1371/journal.pone.0143586.g004
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facial features relying on temporal and frontal neural networks. Features that are invariant to
emotion, like those identifying gender, are still recognized, as this ability depends on posterior
occipital areas that are fully or largely preserved during early stages of AD [12]. We found cor-
relations between emotion recognition performance and the volumes of the expected brain
structures. However, a new finding was that emotion recognition performance was negatively
correlated with most of the grey matter volumes of regions of interest. In particular, fear recog-
nition performance was negatively correlated with the amygdala volumes, whether these were
measured automatically or manually. These unexpected results mean that larger regional vol-
umes are associated with lower performance. We had initially hypothesized that the most atro-
phied regions would be associated with the most impaired cognitive functions.
Emotion impairment in mild stages of AD
Recognition of emotion is impaired in mild stages of AD. We found that emotion recog-
nition was impaired during mild stages of AD. Previous reports on early AD identified distinct
deficits in episodic memory and milder deficits of executive, language and visual functions [4].
Some epidemiological studies have highlighted unexpected signs at very early stages of AD
such as impaired semantic abilities [4], and this may help to understand and characterize clini-
cal presentation at the predementia stage. Demonstrating early changes in social cognition in
AD may be essential for understanding the social disinvestment observed in the first stages of
the disease.
Unlike Spoletini et al. [8], who found that amnestic MCI patients were only impaired in the
recognition of low-intensity fearful faces, we found that patients were impaired in the recogni-
tion of each of several different emotions (anger, fear, happiness, and, to a lesser degree, dis-
gust). Such results were also shown by Bediou et al. [3].
Disgust recognition is selectively preserved. Disgust recognition appeared to be selec-
tively preserved, except at the morphing degree of 40%. This is congruent with the study by
Henry et al. [5] and may be explained by the relative preservation of the basal ganglia in AD
[40], despite significant atrophy of the insula, the two structures previously found to play a role
in disgust recognition [41]. Bediou et al. had found that disgust recognition was preserved in
MCI but not in mild AD, which is partially consistent with our results [3].
The impairment is specific to emotion recognition. Patients were neither impaired on
gender recognition, nor on neutral expression recognition. Thus, their ability to recognize
facial features invariant to emotion was preserved, as well as their visual and attention skills.
Our results indicate that in MCI and mild AD, emotion recognition is impaired specifically,
rather than as a consequence of global cognitive dysfunction.
Neuroanatomical correlates of emotion recognition
The correlations between emotion recognition performance and regional volumes revealed
networks encompassing the regions for which involvement was predicted, even though the
direction of the correlation was unexpected. Our findings showing negative correlations
between the amygdala volumes and the recognition of fear 100% were confirmed by the man-
ual segmentation of the amygdala [39] and persisted even after correction for multiple compar-
isons. To our knowledge, previous studies have not investigated the neuroanatomical correlates
of emotion recognition in the mild stages of AD in such detail.
The total emotion recognition score was negatively correlated with the amygdala volume
(bilaterally) and the left hippocampal volume, and was positively correlated with the left ante-
rior cingulate gyrus and the right medial orbital gyrus volumes. These four regions are acti-
vated in subjects looking at emotionally expressive faces [17]. Regional involvement was
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entirely consistent with our hypotheses: anger recognition correlated with the OFC volume as
well as the ventral striatum volume, fear recognition with the amygdala volume, and happiness
recognition with the fusiform gyrus volume.
We did not find the expected correlation between the insula volume and disgust recogni-
tion. Disgust recognition is processed in the ventral anterior subregion of the insula. The
83-region Hammers atlases currently label the insula as a whole, which may explain the
absence of a correlation in our study.
Hypotheses to explain negative correlations
Contrary to our expectations, we only found negative correlations between emotion recogni-
tion performance and grey matter volumes of a priori specified regions of interest. Some
hypotheses are presented below to explain why patients with larger volumes may show reduced
performance.
The traditional interpretation of atrophy of these regions leading to impaired cognitive abil-
ities is regularly found correct in later stages of Alzheimer’s disease [6], when e.g. hippocampus
volume is positively correlated with memory performance [42, 43].
Amyloid plaque bulk hypothesis. A study by Bussière et al. [44] estimated the volume
occupied by amyloid deposits in the hippocampus, the entorhinal cortex, and area 9 of the
frontal cortex. On average, the β-amyloid volume represented 7.3% of the regional volume,
with values ranging from 0% to 34.8% [44]. Moreover, patients who had received anti-β amy-
loid treatment with AN1792 to eradicate amyloid plaques showed decreased regional volumes.
Evidently, amyloid plaques occupy space and increase regional volumes. At early stages of the
disease, the amount of amyloid deposits is thus correlated with some cognitive impairment, in
particular memory, and hippocampal atrophy [45]. In order to validate this hypothesis, one
might use positron emission tomography with an amyloid tracer to estimate regional β-amy-
loid burden.
Neuroinflammation hypothesis. In mild AD, amyloid plaques are associated with an
inflammatory response involving an increased presence of activated complement proteins,
cytokines, and activated microglia and astrocytes. Neuroinflammation occurs mostly in the
frontal neocortex and limbic system, and precedes cerebral atrophy. The volume occupied by
microglia and macrophages increases with the severity of the dementia [46].
It is therefore possible that the regions with the largest volumes are those with the highest
degree of neuroinflammation. This hypothesis could be tested by assessing the severity of neu-
roinflammation by positron emission tomography with markers for activated microglia, e.g.
[11C]PK11195.
As neuroinflammation may be correlated with β-amyloid burden [47], the neuroinflamma-
tion and amyloid hypotheses both predict increased regional volume to be correlated with cog-
nitive impairment [48].
Hypercompensation hypothesis. In MCI, functional compensatory mechanisms [49]
involving up-regulation of neurotransmitter receptors [50] or enzymes [51] can occur. For
instance, increased hippocampal activation was reported in the MCI stage of AD compared to
controls [52]. Structural compensation with neuronal hypertrophy in neurodegenerative dis-
eases has also been suggested [53]. The most functionally impaired regions may be structurally
compensating the most.
Our findings also point out the fact that, with MCI patients, structural MRI might not
inform properly about the impairments encountered by the patients. Indeed, at the first stages
of AD, neuronal death might be underestimated on MR scans since processes like inflamma-
tion or amyloid deposits might contribute to relative preservation of some brain region
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volumes. A complementary method such as PET with selective ligands may help to disentangle
these pathological mechanisms.
Emotion recognition network
Structural co-variance is increasingly recognized as relevant for studying brain function in
health and disease [54]. We found evidence for structural co-variance in emotion recognition
networks in our study. Fig 4 illustrates that regions for which the correlation with emotion rec-
ognition has the same direction are positively correlated amongst themselves, whereas no clear
correlations were seen when considering all regions of interest in random order. This may indi-
cate that regional involvement in each kind of emotion recognition follows distinct patterns,
which supports the locationist view that postulates unique regional networks for each emotion
[17].
Limitations and perspectives. The patient group consisted of a mixed population of MCI
and AD at mild stage, even if the MCI patients included were typical of the form converting
into AD. Moreover, controls did not undergo MRI, which prevented volume comparisons
between the two groups. MAPER has previously been shown to robustly identify signature
structural differences between healthy controls and MCI and AD patients [14].
In future studies, structural connectivity using DTI between the regions of interest could be
explored. The functional overactivation hypothesis could be explored with functional MRI, the
β-amyloid burden with amyloid PET, or the neuroinflammation hypothesis with activated
microglia PET.
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